Terbinafine
Product Images NDC 68788-7722

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 68788-7722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terbinaine Tablet 250mg (250mg 30tabs)

Terbinafine Tablet 250mg label from Preferred Pharmaceuticals, Inc. The label indicates the medication is generic for Lamisil and manufactured by Cipla USA, Inc. It includes storage instructions, warnings, and administration directions in English and Spanish on a yellow background. Spaces for lot, expiration date, batch number, and insurance information are provided but not filled in.*

FDA Label Image

Image 2 (Terbinafine Str)

Chemical structure diagram of the active ingredient Terbinafine Hydrochloride, showing its molecular components including aromatic rings and an aliphatic chain with a tertiary amine and isopropenyl groups.*

FDA Label Image

Image 1 (Terbinafine Table)

A data table presenting adverse events and discontinuation rates for Terbinafine Tablets compared to placebo. It lists percentages for symptoms including headache, gastrointestinal symptoms (diarrhea, dyspepsia, abdominal pain, nausea, flatulence), dermatological symptoms (rash, pruritus, urticaria), liver enzyme abnormalities, taste disturbance, and visual disturbance in patients taking Terbinafine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.